- Novartis is seeking court order blocking copies until patents have expired and cash compensation if copies are made before then, according to
complaintfiled Friday in federal court in Wilmington, Delaware
- Patents expire in August 2033:
- Novartis last week
filed suitin Delaware against Alkem, Aurobindo, Dr. Reddy’s, Hetero, Laurus, Macleodsand Torrentover patent issued last month related to Entresto
- Novartis in 2019 sued those companies and ...
Sept. 27, 2021, 3:33 PM